KR101551590B1 - 신체 조직의 물리적 및/또는 화학적 성질에 영향을 주는 광화학적 요법 - Google Patents

신체 조직의 물리적 및/또는 화학적 성질에 영향을 주는 광화학적 요법 Download PDF

Info

Publication number
KR101551590B1
KR101551590B1 KR1020147016403A KR20147016403A KR101551590B1 KR 101551590 B1 KR101551590 B1 KR 101551590B1 KR 1020147016403 A KR1020147016403 A KR 1020147016403A KR 20147016403 A KR20147016403 A KR 20147016403A KR 101551590 B1 KR101551590 B1 KR 101551590B1
Authority
KR
South Korea
Prior art keywords
eye
photoinitiator
tissue
medicament according
photoinitiator compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020147016403A
Other languages
English (en)
Korean (ko)
Other versions
KR20140096371A (ko
Inventor
다니얼 엠 슈왈츠
메튜 에스 멧슨
줄리아 에이 콘필드
로버트 케이 말로니
로버트 에이치 그럽스
Original Assignee
캘리포니아 인스티튜트 오브 테크놀로지
더 리젠츠 오브 더 유니버시티 오브 캘리포니아
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 캘리포니아 인스티튜트 오브 테크놀로지, 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 filed Critical 캘리포니아 인스티튜트 오브 테크놀로지
Publication of KR20140096371A publication Critical patent/KR20140096371A/ko
Application granted granted Critical
Publication of KR101551590B1 publication Critical patent/KR101551590B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/0079—Methods or devices for eye surgery using non-laser electromagnetic radiation, e.g. non-coherent light or microwaves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
    • A61F2009/00865—Sclera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
    • A61F2009/00872—Cornea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F2009/00885—Methods or devices for eye surgery using laser for treating a particular disease
    • A61F2009/00893—Keratoconus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Electromagnetism (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020147016403A 2006-10-24 2007-10-24 신체 조직의 물리적 및/또는 화학적 성질에 영향을 주는 광화학적 요법 Expired - Fee Related KR101551590B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US85394906P 2006-10-24 2006-10-24
US60/853,949 2006-10-24
US95454107P 2007-08-07 2007-08-07
US60/954,541 2007-08-07
PCT/US2007/082435 WO2008052081A2 (en) 2006-10-24 2007-10-24 Photochemical therapy to affect mechanical and/or chemical properties of body tissue

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020097009723A Division KR101502632B1 (ko) 2006-10-24 2007-10-24 신체 조직의 물리적 및/또는 화학적 성질에 영향을 주는 광화학적 요법

Publications (2)

Publication Number Publication Date
KR20140096371A KR20140096371A (ko) 2014-08-05
KR101551590B1 true KR101551590B1 (ko) 2015-09-08

Family

ID=39325405

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020147016403A Expired - Fee Related KR101551590B1 (ko) 2006-10-24 2007-10-24 신체 조직의 물리적 및/또는 화학적 성질에 영향을 주는 광화학적 요법
KR1020097009723A Active KR101502632B1 (ko) 2006-10-24 2007-10-24 신체 조직의 물리적 및/또는 화학적 성질에 영향을 주는 광화학적 요법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020097009723A Active KR101502632B1 (ko) 2006-10-24 2007-10-24 신체 조직의 물리적 및/또는 화학적 성질에 영향을 주는 광화학적 요법

Country Status (5)

Country Link
US (1) US8414911B2 (enExample)
JP (1) JP5559540B2 (enExample)
KR (2) KR101551590B1 (enExample)
SG (1) SG175568A1 (enExample)
WO (1) WO2008052081A2 (enExample)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100266989A1 (en) 2006-11-09 2010-10-21 Klox Technologies Inc. Teeth whitening compositions and methods
WO2008124009A2 (en) * 2007-04-02 2008-10-16 The Cleveland Clinic Foundation Treating glaucoma
WO2009073213A1 (en) * 2007-12-05 2009-06-11 Avedro, Inc. Eye therapy system
CZ18420U1 (cs) * 2008-01-25 2008-04-07 Benedík@Jaroslav Prístroj na zjištování kvality a pevnosti cévní steny
WO2009114513A2 (en) * 2008-03-14 2009-09-17 Euclid Systems Corporation Ultraviolet irradiation to treat corneal weakness disorders
GB0816399D0 (en) * 2008-09-09 2008-10-15 Sharma Anant Irradiation treatment
WO2010039854A1 (en) * 2008-09-30 2010-04-08 Neal Marshall Eye therapy system
LT2352488T (lt) 2008-11-07 2017-05-25 Klox Technologies Inc. Oksidacinė fotoaktyvuojama odos atjauninimo kompozicija, apimanti hialurono rūgštį, gliukozaminą arba alantoiną
SMT201700575T1 (it) 2009-07-17 2018-01-11 Klox Tech Inc Composizione orale antibatterica
US20110077468A1 (en) * 2009-09-30 2011-03-31 Finger Paul T Drug eluting eyelid speculum
US8574277B2 (en) 2009-10-21 2013-11-05 Avedro Inc. Eye therapy
DE102010008146B4 (de) 2010-02-12 2022-03-31 Carl Zeiss Meditec Ag Messsystem und Verfahren zum Ermitteln des Innendrucks eines Auges sowie Verfahren und System zum Einstellen des Augeninnendrucks
EP2547298B1 (en) * 2010-03-19 2019-05-08 Avedro, Inc. Systems for applying and monitoring eye therapy
DE102010020194B4 (de) 2010-05-07 2022-09-08 Carl Zeiss Meditec Ag Vorrichtung zur Stabilisierung der Augenhornhaut
US9622911B2 (en) 2010-09-30 2017-04-18 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
WO2012154627A2 (en) * 2011-05-06 2012-11-15 California Institute Of Technology Light delivery device and related compositions, methods and systems
US9044308B2 (en) 2011-05-24 2015-06-02 Avedro, Inc. Systems and methods for reshaping an eye feature
JP6122845B2 (ja) * 2011-06-02 2017-04-26 アヴェドロ・インコーポレーテッドＡｖｅｄｒｏ，Ｉｎｃ． 時間ベースの光活性剤の送達又は光活性マーカの存在をモニターするシステム及び方法
KR101962991B1 (ko) 2011-08-23 2019-03-27 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 안질환 및 질병 치료용 박테리오 클로로필 광민감제
WO2013148895A1 (en) 2012-03-29 2013-10-03 Cxl Ophthalmics, Llc Ocular cross-linking system and method for sealing corneal wounds
EP2830627B1 (en) 2012-03-29 2024-05-01 Epion Therapeutics, Inc. Ocular treatment solutions, delivery devices and delivery augmentation methods
EP2830637B1 (en) 2012-03-29 2024-08-21 Epion Therapeutics, Inc. Compositions and methods for treating or preventing diseases associated with oxidative stress
US20130281913A1 (en) 2012-04-20 2013-10-24 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
US11116841B2 (en) 2012-04-20 2021-09-14 Klox Technologies Inc. Biophotonic compositions, kits and methods
EP2872081B2 (en) 2012-07-16 2025-07-16 Avedro, Inc. Systems for corneal cross-linking with pulsed light
CA2884349C (en) 2012-09-14 2019-03-26 Valeant Pharmaceuticals International, Inc. Compositions and methods for teeth whitening
DE102013004482A1 (de) 2013-03-12 2014-09-18 Carl Zeiss Meditec Ag Vorrichtung und Verfahren zur Stabilisierung der Augenhornhaut
ES3041687T3 (en) * 2013-03-14 2025-11-13 Epion Therapeutics Inc Ophthalmic treatment device
US20140276354A1 (en) 2013-03-14 2014-09-18 Klox Technologies Inc. Biophotonic materials and uses thereof
US9498114B2 (en) 2013-06-18 2016-11-22 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
US9498122B2 (en) 2013-06-18 2016-11-22 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
WO2015000058A1 (en) 2013-07-03 2015-01-08 Klox Technologies Inc. Biophotonic compositions comprising a chromophore and a gelling agent for treating wounds
US9920147B2 (en) 2013-09-13 2018-03-20 Brandeis University Polymeric materials having active cross-linkers, methods for making them, and use thereof
AU2015240385B2 (en) 2014-04-01 2019-02-28 Klox Technologies Inc. Tissue filler compositions and methods of use
WO2016069628A1 (en) 2014-10-27 2016-05-06 Avedro, Inc. Systems and methods for cross-linking treatments of an eye
JP2018500468A (ja) 2014-10-31 2018-01-11 クロックス テクノロジーズ インコーポレイテッドＫｌｏｘ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． 光活性性の繊維および織物媒体
WO2016077747A1 (en) 2014-11-13 2016-05-19 Avedro, Inc. Multipass virtually imaged phased array etalon
EP3285704B1 (en) 2015-04-24 2020-11-18 Avedro Inc. Systems for photoactivating a photosensitizer applied to an eye
CA2985368A1 (en) 2015-05-14 2016-11-17 California Institute Of Technology Light adjustable intraocular lenses using upconverting nanoparticles and near infrared (nir) light
WO2016191342A1 (en) 2015-05-22 2016-12-01 Avedro, Inc. Systems and methods for monitoring cross-linking activity for corneal treatments
CN116832158A (zh) 2015-07-21 2023-10-03 艾维德洛公司 用光敏剂治疗眼睛的系统和方法
US10646372B2 (en) 2015-12-03 2020-05-12 Avedro, Inc. Systems and methods for treating an eye with a mask device
DE102016208012A1 (de) 2016-05-10 2017-11-16 Carl Zeiss Meditec Ag Augenchirurgisches Verfahren
WO2019005943A1 (en) 2017-06-28 2019-01-03 California Institute Of Technology LIGHT ADJUSTABLE INTRAOCULAR LENSES USING ASCENDING CONVERSION OF HEART-WOOD NANOPARTICLES AND INFRARED NEAR-LIGHT (NIR)
CA3093065A1 (en) 2018-03-05 2019-09-12 Avedro, Inc. System for eye tracking during eye treatment
WO2019173762A1 (en) 2018-03-08 2019-09-12 Avedro, Inc. Micro-devices for treatment of an eye
CN113316411B (zh) 2018-09-19 2025-01-17 艾维德洛公司 用于眼部治疗期间的眼部追踪的系统及方法
JP7504083B2 (ja) 2018-09-19 2024-06-21 アヴェドロ・インコーポレーテッド 角膜拡張障害を治療するシステム及び方法
WO2020077015A1 (en) 2018-10-09 2020-04-16 Avedro, Inc. Photoactivation systems and methods for corneal cross-linking treatments
US11702546B2 (en) 2018-10-24 2023-07-18 California Institute Of Technology Near-infrared heptamethine dyes for generation of singlet oxygen
CN111140774B (zh) * 2019-01-31 2025-10-14 中国科学院昆明动物研究所 一种可抑制眼轴过度增长的新型光源及其模拟方法、灯具
JP7571038B2 (ja) 2019-02-26 2024-10-22 アヴェドロ・インコーポレーテッド 眼の架橋処置のためのシステム及び方法
JP6853446B2 (ja) * 2019-02-28 2021-03-31 地方独立行政法人神奈川県立産業技術総合研究所 流動体試料の内部構造観察装置及び内部構造解析システム、流動体試料の内部構造観察方法及び内部構造解析方法、並びにセラミックスの製造方法
US11298263B2 (en) * 2019-07-16 2022-04-12 Jack T. Holladay Method of mitigating myopia development and related instrumentation
WO2021026405A1 (en) 2019-08-06 2021-02-11 Avedro, Inc. Photoactivation systems and methods for corneal cross-linking treatments
AU2022232309A1 (en) 2021-03-08 2023-10-12 Avedro, Inc. Systems and methods for generating patient-specific corneal cross-linking treatment patterns
DE102021131244A1 (de) * 2021-11-29 2023-06-01 Philipps-Universität Marburg, Körperschaft des öffentlichen Rechts Orts- und zeitaufgelöste Bestimmung der dermalen Penetration von nicht- oder schwachfluoreszierenden Substanzen

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050271590A1 (en) 2004-05-07 2005-12-08 California Institute Of Technology Treatment of myopia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6161544A (en) 1998-01-28 2000-12-19 Keratoform, Inc. Methods for accelerated orthokeratology
JP2002058695A (ja) 1999-09-03 2002-02-26 Carl Zeiss Jena Gmbh 眼の照射方法及び装置
US20060276777A1 (en) * 2005-04-08 2006-12-07 Coroneo Minas T Corneal shaping
WO2007001926A2 (en) 2005-06-24 2007-01-04 Hyperbranch Medical Technology, Inc. Low-swelling hydrogel sealants for wound repair

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050271590A1 (en) 2004-05-07 2005-12-08 California Institute Of Technology Treatment of myopia

Also Published As

Publication number Publication date
KR101502632B1 (ko) 2015-03-17
KR20140096371A (ko) 2014-08-05
JP2010507686A (ja) 2010-03-11
JP5559540B2 (ja) 2014-07-23
WO2008052081A3 (en) 2008-06-19
SG175568A1 (en) 2011-11-28
US20080114283A1 (en) 2008-05-15
KR20090082392A (ko) 2009-07-30
US8414911B2 (en) 2013-04-09
WO2008052081A8 (en) 2008-08-14
WO2008052081A2 (en) 2008-05-02

Similar Documents

Publication Publication Date Title
KR101551590B1 (ko) 신체 조직의 물리적 및/또는 화학적 성질에 영향을 주는 광화학적 요법
US20150359668A1 (en) Light delivery device and related compositions, methods and systems
US7727544B2 (en) Treatment of myopia
JP4975440B2 (ja) 黄斑変性およびその他の眼科疾患の改善
Dotan et al. Scleral cross-linking using riboflavin and ultraviolet-a radiation for prevention of progressive myopia in a rabbit model
JP2002506013A (ja) 酵素角膜矯正術における角膜硬化剤の使用
US11045352B2 (en) Methods for treatment of dry eye and other acute or chronic inflammatory processes
CN101594904A (zh) 影响身体组织的机械和/或化学性能的光化学治疗
WO2019143293A1 (en) Self-implantable micro-drug-reservoirs for localized and controlled ocular drug delivery
KR20180080314A (ko) 안과용 조성물
RU2466699C1 (ru) Способ лечения кератоконуса роговицы
Hao et al. Suprachoroidal injection of polyzwitterion hydrogel for treating glaucoma
US10278920B1 (en) Drug delivery implant and a method using the same
US11666777B2 (en) Photodynamic therapy technique for preventing damage to the fovea of the eye or another body portion of a patient
Koh et al. The effect of photodynamic therapy with rose bengal on posterior capsule opacification in rabbit eyes
RU2408335C1 (ru) Способ лечения возрастной макулярной дегенерации сетчатки
RU2388436C2 (ru) Способ лечения кератоконуса
HK1139342A (en) Photochemical therapy to affect mechanical and/or chemical properties of body tissue
RU2822406C1 (ru) Способ подготовки склерального аллотрансплантата для склеропластики при прогрессирующей дегенеративной миопии
Rosner et al. Feasibility and safety of laser treatments in eyes with an intraocular implantable miniature telescope
RU2334496C1 (ru) Способ профилактики рубцевания путей оттока, созданных в ходе антиглаукоматозной операции
Jiang et al. Photochemical Crosslinking as an Adjunct for Repairing Corneal Perforations in Rabbits
RU2707792C1 (ru) Способ лечения осложнений вирусных и бактериальных кератоконъюнктивитов у животных с помощью коллагенового кросслинкинга
RU2288677C2 (ru) Способ фотодинамической терапии воспалительных заболеваний переднего отрезка глаза
Mattson Understanding and Treating Eye Diseases: Mechanical Characterization and Photochemical Modification of the Cornea and Sclera

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A16-div-PA0104

St.27 status event code: A-0-1-A10-A18-div-PA0104

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E90F Notification of reason for final refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

Fee payment year number: 1

St.27 status event code: A-2-2-U10-U12-oth-PR1002

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

Fee payment year number: 4

St.27 status event code: A-4-4-U10-U11-oth-PR1001

PR1001 Payment of annual fee

Fee payment year number: 5

St.27 status event code: A-4-4-U10-U11-oth-PR1001

PR1001 Payment of annual fee

Fee payment year number: 6

St.27 status event code: A-4-4-U10-U11-oth-PR1001

PR1001 Payment of annual fee

Fee payment year number: 7

St.27 status event code: A-4-4-U10-U11-oth-PR1001

PR1001 Payment of annual fee

Fee payment year number: 8

St.27 status event code: A-4-4-U10-U11-oth-PR1001

PC1903 Unpaid annual fee

Not in force date: 20230903

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

St.27 status event code: A-4-4-U10-U13-oth-PC1903

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

PC1903 Unpaid annual fee

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20230903

St.27 status event code: N-4-6-H10-H13-oth-PC1903